GFL Ltd

Q3 FY17 Earnings Call Analysis

Finance

Full Stock Analysis
capex: Yesfundraise: No informationrevenue: Category 3margin: Category 3orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- The company has a pending capex of around Rs 250 Crores for the current financial year. - Gujarat Fluorochemicals Limited intends to fund capex plans primarily through internal accruals; as confirmed, they are generating enough cash from operations. - There is no current specific decision on additional debt or equity fundraising; the management will take an appropriate call, especially after the public holding reaches 25% by the end of March. - No numeric guidance or detailed fundraising plan has been shared at this time. - The management stated they will decide on fresh debt or equity only after Board approval and relevant conditions are met.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Most of the capex for the value-added fluoropolymer business has already been done, and product development is almost complete. Commercial sales have started, with ramp-up expected over the next 4-6 quarters, aiming for full capacity utilization by March 31, 2019. - Manufacturing of some new products at the Ranjitnagar plant began in January 2018; environmental clearance for full capacity is in process but may face delays. - Several more projects in polymer specialty fluorochemicals are planned for commercial production starting January 2018. - Capacity optimization efforts are ongoing for the PTFE plant to increase value realization in the next 2-3 months. - Mining operations for fluorspar commissioned in early November 2017; plans to augment capacity with some capex underway. - Capex plans are funded primarily through internal accruals; no immediate fresh debt anticipated. - Future decisions on investments will be made post Board approvals.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Growth expected every year for the next 2-3 years, especially in value-added products. - Value-added products' revenues have grown threefold in value terms and expected to strengthen further. - PTFE business volumes grew 34% quarter-on-quarter, near full capacity utilization with ongoing optimization for increased capacity. - Specialty polymer products commercialization underway with ramp-up expected over next 4-6 quarters; full capacity utilization anticipated by March 31, 2019. - Caustic soda prices and demand expected to remain strong for the next couple of quarters. - New products from the Ranjitnagar plant expected to contribute from January 2018, with ongoing environmental clearance processes. - Overall margin profile improved owing to increased proportion of value-added products, with EBITDA margins rising from ~20% to ~33%.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

No information is provided regarding the same in the latest conference call.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The transcript does not explicitly mention specific current or expected orderbook or pending orders for Gujarat Fluorochemicals Limited. - However, regarding milestones, around 80% of milestone payments from the sale of nine wind farming projects have been received, with the balance expected by November-December. - No direct mention of fresh order inflows, but ramp-up is expected in specialty fluoropolymer products over the next 4-6 quarters. - Fluorspar production has just commenced, which may support upcoming capacity expansion and related orders. - In wind turbine manufacturing, the market is transitioning and expected to normalize by Q4 FY2018. - No numeric guidance or specifics on new orderbook indicated in the call.